Key result
Plasma volume expansion increased cardiac index and decreased systemic vascular resistance, which may benefit severely hypertensive pregnant patients with a low cardiac index.
Why the study?
Do plasma volume expansion and dihydralazine improve haemodynamic parameters in patients with gestational proteinuric hypertension?
Population
10 patients with gestational proteinuric hypertension
Comparison
Plasma volume expansion and dihydralazine vs Baseline haemodynamic status (before treatment)
Design
Case_series
Authors
Loading...
May support targeted volume expansion in low-cardiac-index cases; leaves open confirmation of benefit and safety in trials.
Do plasma volume expansion and dihydralazine improve haemodynamic parameters in patients with gestational proteinuric hypertension?
Volume expansion increases cardiac index and decreases systemic vascular resistance, suggesting therapeutic benefit in severely hypertensive pregnant patients with a low cardiac index.
Belfort et al. (1989) studied Gestational proteinuric hypertension (n=10). Plasma volume expansion and dihydralazine vs. Baseline was evaluated on Haemodynamic changes (PCWP, CI, SVR, BP). Plasma volume expansion increased cardiac index and decreased systemic vascular resistance, which may benefit severely hypertensive pregnant patients with a low cardiac index.